Tandem Diabetes Care Inc (TNDM) — Cash Flow-to-Debt Ratio
Tandem Diabetes Care Inc (TNDM) has a Cash Flow-to-Debt Ratio of 0.01x as of March 2026, meaning its operating cash flow of $11.05 Million could theoretically repay 0% of its total liabilities ($1.02 Billion) in one year. See TNDM free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Tandem Diabetes Care Inc Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Tandem Diabetes Care Inc across 15 annual periods. Also explore net asset momentum of Tandem Diabetes Care Inc to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Tandem Diabetes Care Inc (2011–2025)
Year-by-year debt coverage analysis for Tandem Diabetes Care Inc. For market capitalisation and broader financial context, see Tandem Diabetes Care Inc (TNDM) total market value.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.01x | $-9.72 Million | $725.94 Million | ▼ -138.9% |
| 2024 | 0.03x | $24.23 Million | $704.56 Million | ▲ +169.1% |
| 2023 | -0.05x | $-31.81 Million | $639.03 Million | ▼ -160.5% |
| 2022 | 0.08x | $50.46 Million | $612.84 Million | ▼ -65.1% |
| 2021 | 0.24x | $111.36 Million | $472.02 Million | ▲ +234.8% |
| 2020 | 0.07x | $24.67 Million | $350.11 Million | ▼ -78.0% |
| 2019 | 0.32x | $41.91 Million | $131.13 Million | ▲ +388.2% |
| 2018 | -0.11x | $-8.32 Million | $75.02 Million | ▲ +79.1% |
| 2017 | -0.53x | $-66.14 Million | $124.49 Million | ▼ -2.8% |
| 2016 | -0.52x | $-61.17 Million | $118.32 Million | ▲ +45.8% |
| 2015 | -0.95x | $-58.76 Million | $61.65 Million | ▲ +19.4% |
| 2014 | -1.18x | $-61.38 Million | $51.89 Million | ▼ -15.6% |
| 2013 | -1.02x | $-47.76 Million | $46.68 Million | ▼ -345.9% |
| 2012 | -0.23x | $-33.47 Million | $145.87 Million | ▲ +9.2% |
| 2011 | -0.25x | $-21.55 Million | $85.27 Million | — |